Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bulpitt

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Circulation|January 1, 1982
Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patientsR Fagard, C Bulpitt, P Lijnen, et al.
European Heart Journal|August 1, 1980
Does diet matter in hypertension?A Amery, C Bulpitt, R Fagard, et al.
Transactions of the Ophthalmological Societies of the United Kingdom|April 1, 1977
Corneal oedema and endothelial cell loss after iris-clip lens implantationH Cheng, G D Sturrock, B Rubinstein, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[A comparison of the effects of verapamil and nifedipine on the quality of life]A Palmer, A Fletcher, G Hamilton, et al.
Lancet (London, England)|September 11, 1993
Implications for trials in progress of publication of positive resultsA Fletcher, D Spiegelhalter, J Staessen, et al.
Postgraduate Medical Journal|December 21, 2000
The effect of reminder calls in reducing non-attendance rates at care of the elderly clinicsF Dockery, C Rajkumar, C Chapman, et al.
British Journal of Clinical Pharmacology|September 1, 1990
A comparison of verapamil and nifedipine on quality of lifeA Palmer, A Fletcher, G Hamilton, et al.
The American Journal of Cardiology|May 1, 1983
Long-term converting-enzyme inhibition as a guide to surgical curability of hypertension associated with renovascular diseaseJ Staessen, C Bulpitt, R Fagard, et al.
Anti-Cancer Drugs|May 2, 2000
New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor statusE Jacobs, P C Bulpitt, I G Coutts, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Impairment of renal function in post-myocardial infarct patients treated with sulfinpyrazoneJ Boelaert, P Lijnen, C Bulpitt, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Circulation|January 1, 1982
Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patientsR Fagard, C Bulpitt, P Lijnen, et al.
European Heart Journal|August 1, 1980
Does diet matter in hypertension?A Amery, C Bulpitt, R Fagard, et al.
Transactions of the Ophthalmological Societies of the United Kingdom|April 1, 1977
Corneal oedema and endothelial cell loss after iris-clip lens implantationH Cheng, G D Sturrock, B Rubinstein, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[A comparison of the effects of verapamil and nifedipine on the quality of life]A Palmer, A Fletcher, G Hamilton, et al.
Lancet (London, England)|September 11, 1993
Implications for trials in progress of publication of positive resultsA Fletcher, D Spiegelhalter, J Staessen, et al.
Postgraduate Medical Journal|December 21, 2000
The effect of reminder calls in reducing non-attendance rates at care of the elderly clinicsF Dockery, C Rajkumar, C Chapman, et al.
British Journal of Clinical Pharmacology|September 1, 1990
A comparison of verapamil and nifedipine on quality of lifeA Palmer, A Fletcher, G Hamilton, et al.
The American Journal of Cardiology|May 1, 1983
Long-term converting-enzyme inhibition as a guide to surgical curability of hypertension associated with renovascular diseaseJ Staessen, C Bulpitt, R Fagard, et al.
Anti-Cancer Drugs|May 2, 2000
New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor statusE Jacobs, P C Bulpitt, I G Coutts, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Impairment of renal function in post-myocardial infarct patients treated with sulfinpyrazoneJ Boelaert, P Lijnen, C Bulpitt, et al.
Pageof 6